BANK OF AMERICA CORP /DE/ - PLX PHARMA INC ownership

PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 49 filers reported holding PLX PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of PLX PHARMA INC
ValueSharesWeighting
Q2 2022$71,000
+1675.0%
29,056
+2541.5%
0.00%
Q1 2022$4,000
-93.3%
1,100
-85.5%
0.00%
Q4 2021$60,000
+185.7%
7,580
+592.9%
0.00%
Q3 2021$21,0001,094
+10840.0%
0.00%
Q2 2021$010
-81.1%
0.00%
Q2 2020$0
-100.0%
53
-92.3%
0.00%
Q3 2019$4,000
-63.6%
689
-65.6%
0.00%
Q1 2019$11,0002,000
+199900.0%
0.00%
Q2 2018$01
-50.0%
0.00%
Q3 2017$020.00%
Other shareholders
PLX PHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 36,407$292,0001.70%
FRIESS ASSOCIATES LLC 278,071$2,227,0000.87%
MSD Partners, L.P. 5,625,000$45,057,0000.49%
Park West Asset Management LLC 1,473,218$11,800,0000.23%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 62,673$502,0000.23%
O'Brien Greene & Co. Inc 60,340$483,0000.16%
Eidelman Virant Capital 27,000$219,0000.08%
Heritage Way Advisors, LLC 25,000$200,0000.08%
GW&K Investment Management, LLC 432,871$3,467,0000.03%
Alpine Global Management, LLC 16,380$131,0000.02%
View complete list of PLX PHARMA INC shareholders